PREVIOTOX
LIVE

Serial Number

97882926

Owner

Mira DX, Inc.

Attorney

Jessica L. Rothstein

Filing Date

Apr 11, 2023

Add to watchlist:

No watchlists yet
View on USPTO

PREVIOTOX Trademark

Serial Number: 97882926

PREVIOTOX is a trademark filed by Mira DX, Inc. on April 11, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Mira DX, Inc. (7 trademarks)

Suite 2410
Los Angeles, CA 90025

Entity Type: 03

Trademark Details

Filing Date

April 11, 2023

Registration Date

Not Registered

Published for Opposition

May 21, 2024

Goods & Services

Scientific research services, namely, DNA screening and genetic testing; medical research services, namely, DNA screening and genetic testing; Medical laboratory testing services; medical and scientific research in the field of genetics and DNA analysis; scientific research and development services relating to predicting toxicity in connection with immunotherapy treatments; research and development for the purpose of determining treatment selection in the field of immune oncology; providing scientific and medical research information in the field of genetics and DNA analysis

Specimen collection kits for the collection of saliva for use in DNA screening and genetic testing for medical purposes comprised primarily of swabs for medical purposes and also including collection tubes with caps, all with or without stabilizing reagents and with instructions, printed mailing labels and flat pack cardboard mailing boxes; DNA collection kit comprised of DNA collection laboratory swab and swab handle for medical purposes

Anatomic pathology specimen collection kits for use in genetic testing comprised primarily of saliva and blood collection containers for medical purposes sold empty, printed instructions, printed shipping labels and transport packaging; Blood collection kit comprised of blood collection bag, holder for medical sample tubes and vials, and medical sample tubes and vials; Medical diagnostic apparatus for testing and analysis of DNA and genetic samples for medical purposes; Medical specimen collection devices in the nature of empty tubes and vials for the collection of DNA samples for use in medical testing and analysis of genetics; Saliva collection devices for medical purposes

Medical and laboratory analysis in connection with the treatment of patients; Processing medical test kits and home sample collection kits; medical testing of saliva and blood; Medical testing for diagnostic or treatment purposes; Genetic testing for medical purposes; medical testing for predicting toxicity in connection with immunotherapy treatments; Medical consultancy services; Medical risk assessment services in the nature of predicting toxicity in connection with immunotherapy treatments

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 24, 2025 EXRA
SOU EXTENSION 3 GRANTED
Dec 23, 2025 EX3G
SOU EXTENSION 3 FILED
Dec 23, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Dec 23, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 24, 2025 EXRA
SOU EXTENSION 2 GRANTED
Jun 23, 2025 EX2G
SOU EXTENSION 2 FILED
Jun 23, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Jun 23, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 3, 2025 EXRA
SOU EXTENSION 1 GRANTED
Jan 14, 2025 EX1G
SOU EXTENSION 1 FILED
Jan 14, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 13, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 16, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 21, 2024 NPUB
PUBLISHED FOR OPPOSITION
May 21, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 1, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 15, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 1, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 1, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 1, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 8, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jan 8, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jan 8, 2024 CNRT
ASSIGNED TO EXAMINER
Jan 8, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 5, 2023 NWOS
NEW APPLICATION ENTERED
Apr 14, 2023 NWAP